Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy|Continue
JAMA Ophthalmology
Sign In
Individual Sign In
Sign inCreate an Account
Access through your institution
Sign In
Purchase Options:
Subscribe to the JAMA Ophthalmology journal
Current Issue Past Issues
Year
Day
2024
August July
August 29, 2024
Original Investigation
Quality of Life and Primary Open-Angle Glaucoma in the Ocular Hypertension Treatment Study
Mae O.Gordon,PhD; FengGao,PhD; JohnBurkland,BS; et al.
Abstract Full Text
JAMA Ophthalmol. Published online August 29, 2024. doi:10.1001/jamaophthalmol.2024.3282
This cross-sectional study used 20-year follow-up data from the Ocular Hypertension Treatment Study to determine the impact, if any, of preperimetric glaucoma and early glaucomatous visual field loss on patients’ self-reported vision-related quality of life compared with participants who did not develop glaucoma.
Brief Report
Initial Therapy of Panretinal Photocoagulation vs Anti-VEGF Injection for Proliferative Diabetic Retinopathy
Amer F.Alsoudi,MD; Karen M.Wai,MD; EunaKoo,MD; et al.
Abstract Full Text
JAMA Ophthalmol. Published online August 29, 2024. doi:10.1001/jamaophthalmol.2024.3283
This cohort study compares outcomes of patients with proliferative diabetic retinopathy treated with panretinal photocoagulation (PRP) and subsequent anti–vascular endothelial growth factor (VEGF) injections to a matched cohort of patients treated with anti-VEGF injections and subsequent PRP.
Observation
Sub-Tenon Triamcinolone and Anti-HIV Medication–Induced Cushing Syndrome
BoonkitPurt,MD; AlexanderNugent,MD; Patricia S.Wu,MD; et al.
Abstract Full Text
JAMA Ophthalmol. Published online August 29, 2024. doi:10.1001/jamaophthalmol.2024.3284
This case report describes a diagnosis of iatrogenic Cushing syndrome as a result of sub-Tenon triamcinolone injection in a patient receiving treatment for HIV who presented with decreased visual acuity in both eyes.
Comment & Response
Risk of Keratitis With EGFR Inhibitors Remains Controversial
Shiuan-TzuenSu,MD; James C.-C.Wei,MD, PhD
Abstract Full Text
JAMA Ophthalmol. Published online August 29, 2024. doi:10.1001/jamaophthalmol.2024.3348
Risk of Keratitis With EGFR Inhibitors Remains Controversial—Reply
Kevin Sheng-KaiMa,DDS; RezaDana,MD, MSc, MPH
Abstract Full Text
JAMA Ophthalmol. Published online August 29, 2024. doi:10.1001/jamaophthalmol.2024.3351
August 22, 2024
Original Investigation
Health and the 2024 US Election
A Screening Strategy to Mitigate Vision Impairment by Engaging Adults Who Underuse Eye Care Services
EricSherman,MD; Leslie M.Niziol,MS; Patrice M.Hicks,PhD, MPH; et al.
Abstract Full Text
JAMA Ophthalmol. Published online August 22, 2024. doi:10.1001/jamaophthalmol.2024.3132
This cross-sectional study examines the use of free eye care services for screening to identify eye disease.
-
Invited Commentary
Bringing Eye Care to the PeopleJohn S.Wittenborn,BS; David B.Rein,PhD
JAMA Ophthalmol
Responsiveness to Selective Laser Trabeculoplasty in Open-Angle Glaucoma and Ocular Hypertension
YangfanYang,MD, PhD; KezhengXu,MM; ZidongChen,MD, PhD; et al.
Abstract Full Text
JAMA Ophthalmol. Published online August 22, 2024. doi:10.1001/jamaophthalmol.2024.3133
This post hoc analysis of a randomized clinical trial evaluates the responsiveness of open-angle glaucoma and ocular hypertension to selective laser trabeculoplasty.
-
Invited Commentary
Repeat Selective Laser Trabeculoplasty and Open-Angle GlaucomaJacob A.Kanter,MD; Harry A.Quigley,MD
JAMA Ophthalmol
Invited Commentary
Bringing Eye Care to the People
John S.Wittenborn,BS; David B.Rein,PhD
Abstract Full Text
JAMA Ophthalmol. Published online August 22, 2024. doi:10.1001/jamaophthalmol.2024.3280
Repeat Selective Laser Trabeculoplasty and Open-Angle Glaucoma
Jacob A.Kanter,MD; Harry A.Quigley,MD
Abstract Full Text
JAMA Ophthalmol. Published online August 22, 2024. doi:10.1001/jamaophthalmol.2024.3279
JAMA Ophthalmology Clinical Challenge
Delayed Vision Loss Following Cardiopulmonary Resuscitation
SonyaBesagar,MD; AlexisFlowers,MD; Daniel A.Valenzuela,MD
Abstract Full Text
has active quiz
JAMA Ophthalmol. Published online August 22, 2024. doi:10.1001/jamaophthalmol.2024.2384
A man in his early 50s was admitted to the hospital after acute hypoxemic respiratory failure and cardiac arrest following aspiration, requiring 3 minutes of cardiopulmonary resuscitation. One day after extubation, he noticed blurry vision peripherally and difficulty focusing at near. What would you do next?
Comment & Response
Myopic Maculopathy in Children and Adolescents With High Myopia
Víctor ManuelAsensio-Sánchez,MD
Abstract Full Text
JAMA Ophthalmol. Published online August 22, 2024. doi:10.1001/jamaophthalmol.2024.3215
-
Invited Commentary
Insights Into Childhood Myopic MaculopathyKyokoOhno-Matsui,MD, PhD
JAMA Ophthalmol
Myopic Maculopathy in Children and Adolescents With High Myopia—Reply
FengJiang,MD; MingguangHe,MD, PhD; ZhixiLi,MD, PhD
Abstract Full Text
JAMA Ophthalmol. Published online August 22, 2024. doi:10.1001/jamaophthalmol.2024.3218
-
Invited Commentary
Insights Into Childhood Myopic MaculopathyKyokoOhno-Matsui,MD, PhD
JAMA Ophthalmol
August 15, 2024
Original Investigation
Biomarker Detection and Validation for Corneal Involvement in Patients With Acute Infectious Conjunctivitis
Gerami D.Seitzman,MD; LalithaPrajna,MD, PhD; N. VenkateshPrajna,MD; et al.
Abstract Full Text
open access has audio
JAMA Ophthalmol. Published online August 15, 2024. doi:10.1001/jamaophthalmol.2024.2891
This cross-sectional study evaluates potential biomarkers in patients with acute infectious conjunctivitis.
-
Audio: Biomarker Detection and Validation for Corneal Involvement in Patients With Acute Infectious Conjunctivitis
-
Invited Commentary
Molecular Sequencing and Biomarkers in Acute Infectious ConjunctivitisLiyingLow,PhD; SaaehaRauz,PhD; Darren S. J.Ting,PhD
JAMA Ophthalmol
Ultra-Widefield and Early Treatment Diabetic Retinopathy Study 7-Field Grading of Diabetic Retinopathy
Lloyd PaulAiello,MD, PhD; BarbaraBlodi,MD; XiaoyuGao,MS; et al.
Abstract Full Text
JAMA Ophthalmol. Published online August 15, 2024. doi:10.1001/jamaophthalmol.2024.2890
This cross-sectional study evaluates ultra-widefield vs Early Treatment Diabetic Retinopathy Study 7-field imaging for the capture of diabetic retinopathy.
-
Invited Commentary
Moving Forward to a Wider Retinal Field of ViewConceiçãoLobo,MD, PhD; Ana RitaSantos,PhD; Inês PereiraMarques,MD, PhD
JAMA Ophthalmol
Brief Report
Vitreoretinopathy in Asymptomatic Children With CTNNB1 Syndrome
Emma C.Bedoukian,MS; GraceForbes,BA; DrewScoles,MD, PhD
Abstract Full Text
JAMA Ophthalmol. Published online August 15, 2024. doi:10.1001/jamaophthalmol.2024.2847
This case series of 11 patients with CTNNB1 syndrome reports the presence of familial exudative vitreoretinonpathy detected via fluorescein angiography under anesthesia, which was previously undetected on ophthalmoscopic examination.
-
Invited Commentary
Genetic Testing for Rare Retinal Diseases in Telomere Biology DisordersNatasha F. S.da Cruz,MD, PhD; Audina M.Berrocal,MD
JAMA Ophthalmol
Invited Commentary
Molecular Sequencing and Biomarkers in Acute Infectious Conjunctivitis
LiyingLow,PhD; SaaehaRauz,PhD; Darren S. J.Ting,PhD
Abstract Full Text
JAMA Ophthalmol. Published online August 15, 2024. doi:10.1001/jamaophthalmol.2024.3091
Health and the 2024 US Election
Moving Forward to a Wider Retinal Field of View
ConceiçãoLobo,MD, PhD; Ana RitaSantos,PhD; Inês PereiraMarques,MD, PhD
Abstract Full Text
JAMA Ophthalmol. Published online August 15, 2024. doi:10.1001/jamaophthalmol.2024.3071
Genetic Testing for Rare Retinal Diseases in Telomere Biology Disorders
Natasha F. S.da Cruz,MD, PhD; Audina M.Berrocal,MD
Abstract Full Text
JAMA Ophthalmol. Published online August 15, 2024. doi:10.1001/jamaophthalmol.2024.2947
Comment & Response
Challenges in Assessing Dose-Dependent Atropine for Myopia
Jan-RoelofPolling,PhD; Caroline C. W.Klaver,MD, PhD
Abstract Full Text
JAMA Ophthalmol. Published online August 15, 2024. doi:10.1001/jamaophthalmol.2024.3074
-
Invited Commentary
Atropine Eye Drops for Myopia Control in Childhood—More Long-Term Data, PleaseMichael X.Repka,MD, MBA
JAMA Ophthalmol
Challenges in Assessing Dose-Dependent Atropine for Myopia—Reply
YongLi,MD; AudreyChia,PhD; MarcusAng,PhD
Abstract Full Text
JAMA Ophthalmol. Published online August 15, 2024. doi:10.1001/jamaophthalmol.2024.3078
-
Invited Commentary
Atropine Eye Drops for Myopia Control in Childhood—More Long-Term Data, PleaseMichael X.Repka,MD, MBA
JAMA Ophthalmol
August 8, 2024
Original Investigation
Neighborhood-Level Social Determinants of Health and Presenting Characteristics for Rhegmatogenous Retinal Detachments
Sally S.Ong,MD; DiepTran,MSc; ErikWestlund,PhD; et al.
Abstract Full Text
has audio
JAMA Ophthalmol. Published online August 8, 2024. doi:10.1001/jamaophthalmol.2024.2889
This cohort study investigates the association between neighborhood-level social determinants of health and severity of rhegmatogenous retinal detachments at presentation.
-
Audio: Neighborhood-Level Social Determinants of Health and Presenting Characteristics for Rhegmatogenous Retinal Detachments
-
Invited Commentary
Implications of Neighborhood- and Patient-Level Factors for Eye CarePatrice M.Hicks,PhD, MPH; Maria A.Woodward,MD, MS; Paula AnneNewman-Casey,MD, MS
JAMA Ophthalmol
Vitrectomy as an Adjunct to Treat-and-Extend Anti-VEGF Injections for Diabetic Macular Edema: The Vitrectomy in Diabetic Macular Oedema (VIDEO) Randomized Clinical Trial
Matthew J.Maguire,MBBS; AlistairLaidlaw,MD; ChristopherHammond,MD; et al.
Abstract Full Text
free access
JAMA Ophthalmol. Published online August 8, 2024. doi:10.1001/jamaophthalmol.2024.2777
This randomized clinical trial examined rates of recruitment and efficacy outcomes of vitrectomy plus internal limiting membrane peeling adjunctive to a treat-and-extend anti–vascular endothelial growth factor (VEGF) injection regimen for diabetic macular edema.
Invited Commentary
Implications of Neighborhood- and Patient-Level Factors for Eye Care
Patrice M.Hicks,PhD, MPH; Maria A.Woodward,MD, MS; Paula AnneNewman-Casey,MD, MS
Abstract Full Text
JAMA Ophthalmol. Published online August 8, 2024. doi:10.1001/jamaophthalmol.2024.3066
August 1, 2024
Original Investigation
Endophthalmitis Rates and Types of Treatments After Intraocular Procedures
Brian L.VanderBeek,MD, MPH, MSCE; YinengChen,MS; MaurizioTomaiuolo,PhD; et al.
Abstract Full Text
JAMA Ophthalmol. Published online August 1, 2024. doi:10.1001/jamaophthalmol.2024.2749
This cohort study examines 20 years of data to determine how rates of endophthalmitis after intraocular procedures have changed over time and how the treatment of those patients has changed.
-
Invited Commentary
Changes in Rates of Postprocedural Endophthalmitis and TreatmentsSeyyedehfatemehGhalibafan,MD; Harry W.Flynn,MD; Nicolas A.Yannuzzi,MD
JAMA Ophthalmol
Invited Commentary
Changes in Rates of Postprocedural Endophthalmitis and Treatments
SeyyedehfatemehGhalibafan,MD; Harry W.Flynn,MD; Nicolas A.Yannuzzi,MD
Abstract Full Text
JAMA Ophthalmol. Published online August 1, 2024. doi:10.1001/jamaophthalmol.2024.2805
JAMA Ophthalmology Clinical Challenge
Acute Bilateral Periorbital Edema in a Psychiatric Patient
Kaela N.Acuff,BS; George A.Villatoro,MD; Sally L.Baxter,MD, MSc
Abstract Full Text
has active quiz
JAMA Ophthalmol. Published online August 1, 2024. doi:10.1001/jamaophthalmol.2024.2815
An older patient with history of alcohol use disorder was admitted for altered mental status and received valproic acid and olanzapine from the psychiatric service. On hospital day 2, the patient acutely developed bilateral periorbital edema. What would you do next?
Get the latest from JAMA Ophthalmology
Sign Up
Privacy Policy | Terms of Use
Latest Issue
Dosing vs Assessment Intervals With Faricimab and Aflibercept
Viewpoint | August 1, 2024
Prophylactic Intracameral Antibiotics and Endophthalmitis After Cataract Surgery
Original Investigation | August 1, 2024
Capsular Tension Ring Implantation for Intraocular Lens Decentration and Tilt in Highly Myopic Eyes: A Randomized Clinical Trial
Original Investigation | August 1, 2024
View More
X
.
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)—
Sign in or create a free account
Access your subscriptions
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Get full journal access for 1 year
Get unlimited access and a printable PDF ($40.00)—
Sign in or create a free account
Sign in to access free PDF
Add or change institution
Free access to newly published articles
To register for email alerts, access free PDF, and more
Save your search
Free access to newly published articles
To register for email alerts, access free PDF, and more
Purchase access
Customize your interests
Free access to newly published articles
To register for email alerts, access free PDF, and more
Create a personal account or sign in to:
- Register for email alerts with links to free full-text articles
- Access PDFs of free articles
- Manage your interests
- Save searches and receive search alerts
Privacy Policy
Make a comment
Free access to newly published articles
To register for email alerts, access free PDF, and more
Create a personal account or sign in to:
- Register for email alerts with links to free full-text articles
- Access PDFs of free articles
- Manage your interests
- Save searches and receive search alerts
Privacy Policy
